In subacute to chronic phases of ischemic stroke, C3a–C3a receptor signaling stimulated post-stroke synaptogenesis and axonal plasticity, and intranasal treatment with C3a receptor agonists improved functional recovery (116). This evidence concerns the gene C3 and Stroke.